These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22922883)

  • 1. Association of autotaxin and lysophosphatidic acid receptor 3 with aggressiveness of human breast carcinoma.
    Popnikolov NK; Dalwadi BH; Thomas JD; Johannes GJ; Imagawa WT
    Tumour Biol; 2012 Dec; 33(6):2237-43. PubMed ID: 22922883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of autotaxin and lysophosphatidic acid receptors 1 and 3 in the developing rat lung and in response to hyperoxia.
    Shim GH; Kim HS; Kim ES; Lee KY; Kim EK; Choi JH
    Free Radic Res; 2015; 49(11):1362-70. PubMed ID: 26178778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autotaxin/Lpar3 signaling regulates Kupffer's vesicle formation and left-right asymmetry in zebrafish.
    Lai SL; Yao WL; Tsao KC; Houben AJ; Albers HM; Ovaa H; Moolenaar WH; Lee SJ
    Development; 2012 Dec; 139(23):4439-48. PubMed ID: 23095890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
    Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
    Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
    Yu X; Zhang Y; Chen H
    BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of the altered expression of lysophosphatidic acid receptors, autotaxin and phospholipase A2 as the potential biomarkers in type 1 endometrial cancer biology.
    Wasniewski T; Woclawek-Potocka I; Boruszewska D; Kowalczyk-Zieba I; Sinderewicz E; Grycmacher K
    Oncol Rep; 2015 Nov; 34(5):2760-7. PubMed ID: 26327335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
    Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
    Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Syndecan-1 Immunohistochemical Expression in Lobular and Ductal Breast Carcinoma with Nodal Metastases.
    Miše I; Vučić M
    Anal Cell Pathol (Amst); 2018; 2018():9432375. PubMed ID: 30151336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
    Tabuchi S
    Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma.
    Onallah H; Catane LJ; Tropé CG; Hetland Falkenthal TE; Reich R; Davidson B
    Virchows Arch; 2018 Oct; 473(4):463-470. PubMed ID: 30032361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased N-myc downstream-regulated gene 1 expression is associated with breast atypia-to-carcinoma progression.
    Mao XY; Fan CF; Wei J; Liu C; Zheng HC; Yao F; Jin F
    Tumour Biol; 2011 Dec; 32(6):1271-6. PubMed ID: 21909787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autotaxin-lysophosphatidic acid-LPA
    Aikawa S; Kano K; Inoue A; Wang J; Saigusa D; Nagamatsu T; Hirota Y; Fujii T; Tsuchiya S; Taketomi Y; Sugimoto Y; Murakami M; Arita M; Kurano M; Ikeda H; Yatomi Y; Chun J; Aoki J
    EMBO J; 2017 Jul; 36(14):2146-2160. PubMed ID: 28588064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
    Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
    Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autotaxin and LPA receptor signaling in cancer.
    Houben AJ; Moolenaar WH
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
    Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A
    BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients.
    Ranogajec I; Jakić-Razumović J; Puzović V; Gabrilovac J
    Med Oncol; 2012 Jun; 29(2):561-9. PubMed ID: 21611838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.
    Alemayehu M; Dragan M; Pape C; Siddiqui I; Sacks DB; Di Guglielmo GM; Babwah AV; Bhattacharya M
    PLoS One; 2013; 8(2):e56174. PubMed ID: 23405264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells.
    Nakopoulou L; Giannopoulou I; Lazaris ACh; Alexandrou P; Tsirmpa I; Markaki S; Panayotopoulou E; Keramopoulos A
    APMIS; 2003 Nov; 111(11):1027-36. PubMed ID: 14629269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Autotaxin⁻Lysophosphatidate Signaling-Related Proteins in Breast Cancer with Adipose Stroma.
    Cha YJ; Koo JS
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric mammary carcinoma: evidence of monoclonal proliferation.
    Middleton LP; Vlastos G; Mirza NQ; Eva S; Sahin AA
    Cancer; 2002 Apr; 94(7):1910-6. PubMed ID: 11932891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.